Case Conceptualization and Treatment Planning: Integrating Theory with Clinical Practice (Fourth Edition)Pearl S.Berman, SAGE Publications, Inc., USA, 2019. ISBN: 9781506331386, PB, 692 pages

2019 ◽  
Vol 40 (4) ◽  
pp. 486-487
Author(s):  
Mark Mahemoff
Liver Cancer ◽  
2021 ◽  
pp. 1-43
Author(s):  
Masatoshi Kudo ◽  
Yusuke Kawamura ◽  
Kiyoshi Hasegawa ◽  
Ryosuke Tateishi ◽  
Kazuya Kariyama ◽  
...  

The Clinical Practice Manual for Hepatocellular Carcinoma was published based on evidence confirmed by the Evidence-based Clinical Practice Guidelines for Hepatocellular Carcinoma along with consensus opinion among a Japan Society of Hepatology (JSH) expert panel on hepatocellular carcinoma (HCC). Since the JSH Clinical Practice Guidelines are based on original articles with extremely high levels of evidence, expert opinions on HCC management in clinical practice or consensus on newly developed treatments are not included. However, the practice manual incorporates the literature based on clinical data, expert opinion, and real-world clinical practice currently conducted in Japan to facilitate its use by clinicians. Alongside each revision of the JSH Guidelines, we issued an update to the manual, with the first edition of the manual published in 2007, the second edition in 2010, the third edition in 2015, and the fourth edition in 2020, which includes the 2017 edition of the JSH Guideline. This article is an excerpt from the fourth edition of the HCC Clinical Practice Manual focusing on pathology, diagnosis, and treatment of HCC. It is designed as a practical manual different from the latest version of the JSH Clinical Practice Guidelines. This practice manual was written by an expert panel from the JSH, with emphasis on the consensus statements and recommendations for the management of HCC proposed by the JSH expert panel. In this article, we included newly developed clinical practices that are relatively common among Japanese experts in this field, although all of their statements are not associated with a high level of evidence, but these practices are likely to be incorporated into guidelines in the future. To write this article, coauthors from different institutions drafted the content and then critically reviewed each other’s work. The revised content was then critically reviewed by the Board of Directors and the Planning and Public Relations Committee of JSH before publication to confirm the consensus statements and recommendations. The consensus statements and recommendations presented in this report represent measures actually being conducted at the highest-level HCC treatment centers in Japan. We hope this article provides insight into the actual situation of HCC practice in Japan, thereby affecting the global practice pattern in the management of HCC.


Author(s):  
Amy R. Sewart ◽  
Michelle G. Craske

Abstract: Panic disorder refers to recurrent, unexpected panic attacks, followed by at least 1 month of persistent concern about their recurrence and their consequences or a significant maladaptive change in behavior consequent to the attacks. Highly comorbid with panic disorder, agoraphobia refers to marked fear or avoidance of specific situations from which escape is perceived to be difficult or in which help may be unavailable in the event of panic-like or other incapacitating or embarrassing symptoms. This chapter focuses on the assessment of panic disorder and agoraphobia in adults. It begins with a review of the nature of the disorders, which is followed by a review of clinical assessment instruments designed for the assessment purposes of (a) diagnosis, (b) case conceptualization and treatment planning, and (c) treatment monitoring and evaluation. Recommendations are included for instruments with the greatest scientific support and for assessing these anxiety disorders in a clinically sensitive manner.


Author(s):  
Jacqueline B. Persons ◽  
David M. Fresco ◽  
Juliet Small Ernst

Abstract: This chapter focuses on the assessment of depression in adults. It focuses on major depressive disorder (MDD) because the empirical support for the tools and theories and therapies described in this chapter focuses most frequently on MDD. Many other disorders, as well as phenomena that are not disorders (e.g., grief), share features with MDD, and many of the assessment tools described in this chapter will be helpful in those cases as well. The chapter begins with an overview of the nature of the disorder, which is followed by reviews of assessment instruments designed for the purposes of (a) diagnosis, (b) case conceptualization and treatment planning, and (c) treatment monitoring and evaluation. We include recommendations for instruments that have the greatest scientific support and that assess depression in a clinically sensitive manner.


For many professional psychologists, assessment is viewed as a unique and defining feature of their expertise. Criteria for evaluating the scientific evidence supporting clinical instruments are presented in this chapter, including criteria for norms, reliability, validity, and clinical utility. These criteria are used by chapter authors in this volume in their condition-specific reviews of assessment instruments used for (a) diagnosis, (b) case conceptualization and treatment planning, and (c) treatment monitoring and treatment evaluation. Selecting and using scientifically sound instruments is a necessary starting point for evidence-based practice, but a remaining challenge is for professionals to integrate the resulting assessment data in a manner that is itself evidence-based.


With expert input from additional section editors William G. Bennett, Jeremy R. Chapman, Adrian Covic, Marc E. De Broe, Vivekanand Jha, Neil Sheerin, Robert Unwin, and Adrian Woolf, the Oxford Textbook of Clinical Nephrology is a three-volume international textbook of nephrology with an unrivalled clinical approach backed up by science. It has been completely rewritten in 365 chapters for its fourth edition to bring it right up to date, make it easier to obtain rapid answers to questions, and to suit delivery in electronic formats as well as in print. This edition offers increased focus on the medical aspects of transplantation, HIV-associated renal disease, and infection and renal disease, alongside entirely new sections on genetic topics and clinical and physiological aspects of fluid/electrolyte and tubular disorders. The emphasis throughout is on marrying advances in scientific research with clinical management. The target audience is primarily the nephrologist in clinical practice and training as well as other healthcare professionals with an interest in renal disease.


Sign in / Sign up

Export Citation Format

Share Document